Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-26 @ 12:52 AM
Study NCT ID:
NCT06166134
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-12
First Post:
2023-12-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Radiological Evaluation of Sarcopenia in Patient Received Chemotherapy
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D055948', 'term': 'Sarcopenia'}], 'ancestors': [{'id': 'D009133', 'term': 'Muscular Atrophy'}, {'id': 'D020879', 'term': 'Neuromuscular Manifestations'}, {'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D001284', 'term': 'Atrophy'}, {'id': 'D020763', 'term': 'Pathological Conditions, Anatomical'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'CROSS_SECTIONAL', 'observationalModel': 'OTHER'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 72}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'NOT_YET_RECRUITING', 'startDateStruct': {'date': '2024-01', 'type': 'ESTIMATED'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-12', 'completionDateStruct': {'date': '2025-04', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2023-12-08', 'studyFirstSubmitDate': '2023-12-02', 'studyFirstSubmitQcDate': '2023-12-08', 'lastUpdatePostDateStruct': {'date': '2023-12-12', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2023-12-12', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2025-04', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Radiological evaluation of sarcopenia in patients receiving chemotherapy', 'timeFrame': 'April 2025', 'description': 'Using sonoelastography and computed tomography in evaluation of muscle mass in patients received chemotherapy by measurement of muscle thickness ,echogencity ,cross sectional area ,fasicle length,pennation angle, strain ratio,shear wave velocity'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Sarcopenia']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'https://pubmed.ncbi.nlm.nih.gov/36227071/', 'label': 'Related Info'}, {'url': 'https://pubmed.ncbi.nlm.nih.gov/35054402/', 'label': 'Related Info'}]}, 'descriptionModule': {'briefSummary': 'Radiological evaluation of sarcopenia in patients receiving chemotherapy', 'detailedDescription': 'Evaluation of muscle mass by using sonoelastography and computed tomography'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '65 Years', 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Comparison of muscle mass before and after chemotherapy by use of sonoelastography and computed tomography and comparison with normal volunteer', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* all cancer patients receiving chemotherapy referred to radiodiagnosis department for routine examination Patients must be between 18 and\n\nExclusion Criteria:\n\n* Previous or current history of any musculoskeletal or neurological disorder including strokes.\n* Systemic atrophy affecting CNS ( Huntington disease ,hereditary ataxia ,spinal muscular disorder and related syndromes ,post polio syndrome )\n* Central nervous system demyelinating disease ( Multiple sclerosis , acute disseminated demyelinated syndromes..\n* Corticosteroids undertaken currently or for the past 3 years with doses \\>5mg/day.'}, 'identificationModule': {'nctId': 'NCT06166134', 'briefTitle': 'Radiological Evaluation of Sarcopenia in Patient Received Chemotherapy', 'organization': {'class': 'OTHER', 'fullName': 'Assiut University'}, 'officialTitle': 'Radiological Evaluation of Sarcopenia in Patient Received Chemotherapy', 'orgStudyIdInfo': {'id': 'Us and CT in sarcopenia'}}, 'contactsLocationsModule': {'centralContacts': [{'name': 'Doaa Maher ebied Maher, Resident', 'role': 'CONTACT', 'email': 'dm953407@gmail.com', 'phone': '01050147500'}, {'name': 'Hasan ibrahim Megally, Professor', 'role': 'CONTACT', 'email': 'Hasanibrahim48@yahoo.com', 'phone': '01006209584'}], 'overallOfficials': [{'name': 'Lamiaa Refaat, Assisstant professor', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Assiut university -south egypt cancer institute'}, {'name': 'Omar Mostafa, Assisstant professor', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Assiut university -south egypt cancer institute'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Assiut University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Resident doctor', 'investigatorFullName': 'Doaa Maher', 'investigatorAffiliation': 'Assiut University'}}}}